CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
100 hedge funds and large institutions have $301M invested in Concert Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+8
Holders Change %
+8.7%
% of All Funds
1.77%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
34
Reduced
31
Closed
9
Calls
$332K
Puts
$25K
Net Calls
+$307K
Net Calls Change
+$68K
Top Buyers
| 1 |
CA
Corriente Advisors
Fort Worth,
Texas
|
$8.6M |
| 2 |
BlackRock
New York
|
$27.9M |
| 3 |
M&T Bank
Buffalo,
New York
|
$4.77M |
| 4 |
PVI
Pura Vida Investments
New York
|
$3.71M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
$6.79M |
